IL33 and familial dilated cardiomyopathy: In this study, our results indicate that the upregulation of the IL‐33/ST2L axis exerts a pyroptosis‐promoting effect in DCM, and CORM‐2 treatment can ameliorate cardiomyocyte pyroptosis, in part, by downregulating the IL‐33/ST2L axis in DCM mice.